Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bodi Envi vs Wisp

Bodi Envi
Graded #88

Higher grade

vs+7.3999999999999915
Wisp
Graded #243

Lower grade

The verdict

Bodi Envi takes it — 71.8/100 to 64.4/100.

Bodi Envi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation or…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodi Envi +23
73
50
Dose & formulationWisp +4
72
76
Clinical oversightEven
82
82
Labs & monitoringBodi Envi +11
64
53
FulfillmentBodi Envi +3
69
66
Contract termsBodi Envi +6
61
55
Bodi Envi · left barWisp · right bar

The numbers

MetricBodi EnviWisp
WeighScore71.8/10064.4/100
GradeCC
Scorecard rank#88#243
Semaglutide$179/mo$225/mo (compounded oral)
Tirzepatide$249/moNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Bodi Envi

Graded #88 · C

Strengths

  • Transparent flat pricing: compounded semaglutide $179/month and tirzepatide $249/month, all doses
  • No consultation or membership fees
  • Free 2-day shipping included; FSA and HSA eligible
  • 24/7 secure provider messaging with same-day visits and prescriptions
  • Personalized dose titration with side-effect management (Zofran available)

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No insurance billing — cash-pay only
  • States served are not explicitly listed (features vary by state)
  • No LegitScript certification visible on the site
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard